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Background: Intersubtype recombination is a powerful driving force for HIV evolution, impacting both HIV-1
diversity within an infected individual and within the global epidemic. This study examines if viral protein function/
fitness is the major constraint shaping selection of recombination hotspots in replication-competent HIV-1 progeny. A
better understanding of the interplay between viral protein structure-function and recombination may provide insights
into both vaccine design and drug development.
Results: In vitro HIV-1 dual infections were used to recombine subtypes A and D isolates and examine breakpoints in
the Env glycoproteins. The entire env genes of 21 A/D recombinants with breakpoints in gp120 were non-functional
when cloned into the laboratory strain, NL4-3. Likewise, cloning of A/D gp120 coding regions also produced dead
viruses with non-functional Envs. 4/9 replication-competent viruses with functional Env’s were obtained when just the
V1-V5 regions of these same A/D recombinants (i.e. same A/D breakpoints as above) were cloned into NL4-3.
Conclusion: These findings on functional A/D Env recombinants combined with structural models of Env suggest
a conserved interplay between the C1 domain with C5 domain of gp120 and extracellular domain of gp41. Models
also reveal a co-evolution within C1, C5, and ecto-gp41 domains which might explain the paucity of intersubtype
recombination in the gp120 V1-V5 regions, despite their hypervariability. At least HIV-1 A/D intersubtype recombination
in gp120 may result in a C1 from one subtype incompatible with a C5/gp41 from another subtype.Background
A major obstacle for HIV treatment and vaccine devel-
opment is virus diversity which continues to increase
due to its high mutation rate and recombination [1–6].
Intersubtype recombination is shaping HIV evolution by
establishing unique and stable circulating recombinant
forms (URFs and CRFs) in various regional epidemics
[7–14], by contributing to the rapid emergence of multi-
drug resistance [15, 16] and immune escape [17, 18],
and by rescuing HIV-1 from catastrophic mutations via
negative epistasis [19]. In this study, we have explored
the functional constraints that limit intersubtype recom-
bination in the HIV-1 env gene. These mechanistic stud-
ies on HIV-1 recombination can provide valuable insight* Correspondence: yxg18@case.edu
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unless otherwise stated.into chimeric env cloning and production, the basis for
many HIV-1 vaccine designs. Likewise, understanding
the limitations in functional complementation within the
env coding region can be advantageous as a therapeutic
target and for drug design.
The HIV-1 envelope is a glycoprotein trimeric com-
plex found on the viral surface, embedded in the mem-
brane, and composed of the gp120 subunit spikes in a
non-covalent interaction with the gp41 harboring the
transmembrane domain. Each gp120–gp41 subunit is
derived from the proteolytic processing of the envelope
precursor gp160 in the Golgi complex [20, 21]. The en-
velope trimer collectively coordinates entry of HIV-1
into susceptible cells. The gp120 glycoprotein is subdi-
vided into a conserved core derived from five conserved
subdomains (C1–C5) interspersed by five hypervariable,
glycosylated loops (V1-V5) [22, 23]. The C4 region of
gp120 mediates binding to the host CD4 molecule, indu-
cing a conformational change, and promoting inter-
action between gp120 C2 and V3 regions with the N. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The gp41 senses the conformational changes in gp120
and undergoes a radical structural refolding culminating
in the fusion of viral and host cell membranes [24, 25].
The second exons of tat and rev overlap with the gp41
coding region of HIV-1 env, and must be correctly spliced
to join the first exons to produce functional Tat and Rev
proteins which are two essential viral regulatory factors
for HIV gene expression [26, 27]. Thus, any modifications
at the gp120/gp41 coding interface due to the intersubtype
recombination, could alter the correct splicing of the tat
and rev mRNA and possibly disrupt the function of Tat
and Rev proteins. However, significant intersubtype se-
quence variability in both tat and rev sequences exists,
and even in the same subtype Tat and Rev continue to
evolve under selection pressure [28, 29].
We have previously examined the emergence and se-
lection of intersubtype HIV-1 recombinants in single
cycle systems involving replication defective viruses and
in dual infection studies [1, 2, 30, 31]. With increasing
selection for replication competent viruses using various
in vitro systems, we observed a re-distribution of env re-
combination sites within the gp120 coding sequence (no
selection) to breakpoints primarily located in the
gp120/gp41 interface (selection for fully functional
Env’s). Intersubtype recombination within the HIV-1
gp120 coding region could impact complementation
between the subdomains of gp120 and produce Env
glycoproteins that are not properly expressed, modified,
or transported to the cell surface. Intersubtype recom-
binants with breakpoints in gp120 also provide a
unique circumstance to study intermolecular interac-
tions within the HIV-1 envelope. Even when incorpo-
rated into a new virus particle, such chimeric Envs may
be defective for subsequent host cell entry. Likewise, a
recombination breakpoint in the gp120 coding region
of env could also impact the function of the accessory
proteins, Rev and Tat. We have characterized a set of
HIV-1 intersubtype A and D Env recombinants with
breakpoints in the gp120 and gp41 coding region and
have shown that A/D breakpoints between the C1 and C5
domains of gp120 result in non-functional, replication-
defective Env glycoproteins. This study now provides
strong evidence of co-evolution and direct interplay be-
tween the C1, C5, and gp41 domains of the Env glycopro-
teins, necessary for host cell entry and viral infectivity.
Results
Generation of Intersubtype envA/D recombinants
We have previously described dual infection methods to
produce HIV-1 env recombinants [32]. Even though
PBMCs are more relevant in generating recombinants
similar in HIV patients, based on our previous experi-
ence, the infection efficiency of HIV in PBMCs is muchlower than in U87.CD4.CCR5 cell line resulting in very
low levels of recombinant genomes, and the sites of
intersubtype recombination was similar in U87 cells and
PBMCs [1, 2, 30, 31]. In this study, subtype A (A91 and
A115) and D (D109) HIV-1 isolates were used to co-infect
U87.CD4.CCR5 cells. Subtypes A and D co-circulate in
Kenya and Uganda and frequently recombine to generate
A/D URFs, isolated in HIV-infected individuals. We
cloned and sequenced 88 envA/D recombinants from dual
infections of the A91 + D109 and of the A115 + D109
HIV-1 isolates. Of 88 envA/D recombinants, 28 had re-
combination breakpoints within gp120 while the
remaining breakpoints mapped to the highly conserved,
transmembrane coding region of gp41. Seven A/D
gp120 recombinants were excluded based on premature
stop codons or frameshift in the envelope open reading
frame (ORF) or duplicates with the same unique break-
point. The remaining 21 unique A/D recombinants
with breakpoints in gp120, 11 A91/D109 (Fig. 1a) and
10 A115/D109 (Fig. 1b), were used to investigate the
impact of gp120 recombination on Env function. Ex-
cept bk6780 (breakpoint at position 6780) and bk7643,
all of the other breakpoints identified in the gp120 re-
gion were single (Fig. 1).
Full length HIV-1 A/D recombinant envelopes with
breakpoints in gp120 were non-functional when cloned
into NL4-3 backbone
We and others have previously described intersubtype
recombination “hotspots” in the env gene derived from
single-cycle assays, dual infection systems, and recom-
bination enrichment systems involving siRNA selection
[1, 2, 30–33]. With increased selection for replication-
competent viruses, there was limited intersubtype re-
combination within the gp120 coding regions and in-
creased detection of breakpoints in the gp41 coding
regions. In this study, we examined the function of Env
when intersubtype recombination was identified in the
gp120 coding sequence. We first cloned full length env
with A/D gp120 breakpoints (aka env-gp120 A/D) into
pREC_nfl_HIVΔenv/URA3 plasmid (containing an HIV-
1 NL4-3 near full length genome except 5′LTR sequence
as a backbone) (Fig. 2a) using a yeast-based recombin-
ation method [34]. The cloned env-gp120 A/D recombi-
nants in the NL4-3 backbone were tested for their ability
to mediate cell fusion using the Veritrop assay (a surro-
gate of virus entry) as previously described [35]. These
env–gp120 A/D vectors were also co-transfected with a
complementing vector [34] to measure virus production
and subsequent multiple cycle replication.
All of the parental A91, A115 and D109 HIV-1 env
genes in pREC_nfl_HIVNL4-3 mediated robust cell-to-cell
fusion when tested by using the Veritrop assay [35]
(Fig. 3a). However, the 21 env-gp120 A/D recombinants
Fig. 1 Distribution of recombination breakpoints in gp120 region.
Clonal gp120 recombinant sequences were aligned with parental
strains and the recombination breakpoints were determined using
similarity plots constructed in SimPlot sequence analysis software.
Distribution of breakpoint in gp120 region for A91/D109 and A115/
D109 dual infection sets is indicated in (a) and (b) respectively
Bagaya et al. Retrovirology  (2015) 12:44 Page 3 of 17(11 A91/D109 and 10 A115/D109) in pREC_nfl_HIVNL4-
3 did not mediate cell-to-cell fusion (Fig. 3b and c). A
similar outcome was observed with the respective re-
combinant viruses. Spreading virus infections were ob-
served with the NL4-3 containing the parental A91,
A115 and D109 HIV-1 env genes (Fig. 3d) whereas the
viruses with the env-gp120 A/D recombinants were rep-
lication defective (Fig. 3e and f).Impact of chimeric Tat/Rev proteins on replication of A/D
recombinant viruses
HIV-1 Tat and Rev proteins are translated from two
exons. The first exons of tat and rev are located up-
stream of the env gp120 coding region, while tat2 and
rev2 exons are found in the gp41 coding region. In the
pREC_nfl_HIV constructs containing the env-gp120 A/D
recombinants, tat1/rev1 exons are of NL4-3 sequence
and spliced to tat2/rev2 exons of D109 sequence result-
ing in chimeric Rev and Tat proteins. Thus, defective
pREC_nfl_HIV constructs with env-gp120 A/D may be
the consequence of non-functional, chimeric Tat/Rev
accessory proteins rather than the direct consequence of
a chimeric A/D Env glycoprotein. To rule out this possi-
bility, we replaced the NL4-3 tat1 and rev1 exons in the
backbone with the corresponding sequence from isolate
D109 such that both tat/rev exons would be derived
from the same subtype D HIV-1 isolate in the env-gp120
A/D recombinants (see Methods) (Fig. 2b). Two of the
21 env-gp120 A/D recombinants, one from the set of
A91/D109 (Fig. 4b and e) and one from A115/D109
(Fig. 4c and f), were functional upon introduction of the
concordant D109 tat1 and rev1 exons. This result sug-
gests that in some instances, chimeric A/D Tat and Rev
proteins can restrict or reduce HIV-1 replication of some
intersubtype recombinants with breakpoints appearing in
the gp120 coding region of env. However, the majority of
env-gp120 A/D recombinants remained non-functional in-
dicating that sequence concordance in the first and sec-
ond exon of tat/rev is not the primary cause of this
restriction. Please note that vpu in the cloned HIV-1 viral
genome is also chimeric (B/A). However, the constructs
with the primary envs containing the same vpu produced
replicative viruses (Fig. 3a and d) suggesting that it has no
significant influence in the replication capacity.
Fig. 2 Systematic strategies for cloning envA/D recombinant sequences. (a) Full envA/D recombinants were cloned into a plasmid containing a near
full length HIV-1 NL4-3 backbone; (b) plasmids cloned in panel A were modified by insertion of tat1, rev1 and vpu from isolate D109 to match the
corresponding tat2 and rev2 sequences; (c) selected gp120 recombinants from panel B were cloned such that NL4-3 gp41 was unaltered; (d) only V1-
V5 of recombinant gp120 sequences was cloned in order to preserve the consistency between C1, C5, and gp41 domains. Subtype A sequences
(A115 and A91) are denoted by red lines, and subtype D (D109) sequences are denoted by green lines
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recombinant viruses
The gp120 region of the HIV-1 envelope is responsible for
CD4 binding, coreceptor recognition, immunogenicity,
immune evasion, interactions with gp41, and coordinating
the host cell entry process. Thus, intersubtype recombin-
ation in gp120 can result in a significant shift in genetic
differences and could result in a non-functional envelope
on the viral surface. By cloning just the A/D gp120 region
into the NL4-3 backbone, there was no disruption of an-
other HIV-1 coding region and we could retain tat and
rev genes from the NL4-3 backbone. Thus, we could
examine the impact of intersubtype recombination sites
on gp120 function (in association with other interacting
proteins, e.g. gp41). On the other hand, based on possible
interactions between the N and C-terminus of gp120 in
the crystal structure [36–38], we suspect that the function
of A/D recombinants with breakpoints in V1-V5 domains
might be maintained if retaining the NL4-3 C1 and C5 do-
mains. Cloning the parental A91, A115 and D109 V1-V5
region into the NL4-3 backbone resulted in functional
Env and replication competent virus suggesting again that
this subtype B NL4-3 virus could accommodate a diverse
chimeric Env glycoprotein.
For these analyses, we cloned either the entire gp120
coding region or only V1-V5 region of 9 A/D gp120recombinants with breakpoints in gp120 (bk6684, bk7149,
bk7336, and bk7581 from A91/D109, and bk6765, bk6780,
bk6915, bk7179, and bk7376 from A115/D109), all con-
taining breakpoints within V1-V5 regions into NL4-3
backbone (Fig. 2c and 2d). We excluded the analyses of
gp120 A/D recombinants which contained breakpoints ei-
ther in C1 or C5 region (i.e. bk6278, bk4406, bk6411,
bk7169, bk7644, bk7676, bk7704, bk6527, bk6555,
bk6915, bk7334, bk7643, and bk7652). The cloning of the
entire gp120 coding regions of these 9 A/D gp120 recom-
binants resulted in none of functional Env glycoprotein by
Veritrop or replication defective virus (Fig. 5a and b).
Please note that all 9 A/D gp120 coding regions cloned
into NL4-3 backbone resulted in production of recombin-
ant Env glycoproteins on the viral surface as demonstrated
by EIA using plates coated with anti-gp120 antibody B13
(Fig. 5c), as well as Western blot (Fig. 5d). Interestingly, 4
out of 9 A/D V1-V5 regions cloned into an NL4-3 back-
bone (in between the C1 and C5 regions of NL4-3) re-
sulted in functional Env glycoproteins and replication
competent viruses (Fig. 6a and b). Although bk6684
(breakpoint at V1/V2 region), bk7149 (V3), bk7336 (C3),
and bk7376 (C3) could not replicate or produce functional
Env when cloned as a whole Env or gp120, the cloning of
V1-V5 region of these A/D recombinants successfully res-
cued their function (Fig. 6a and b).
Fig. 3 Function assay of HIV-1 envelope recombinants with breakpoints in gp120 when entirely cloned into NL4-3 backbone. Parental HIV-1
isolates A91, A115 and D109 envs, and envA/D recombinants of A91/D109 and A115/D109 with breakpoints in gp120 region were cloned with the
entire env sequences into NL4-3. Veritrop assay (fusion/function assay) and virus propagation results of parental envelopes (a and d), env recombinants
from A91/D109 pair (b and e) and from A115/D109 set (c and f) are plotted
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C1, C5, and ecto-gp41 domains
Our studies on intersubtype recombination in env as
well as sequence analyses of patient-derived URFs and
CRFs revealed that breakpoints are rarely observed in
the V1-V5 gp120 coding region. There are only 4 listed
A/D CRFs (and 1 A1DG), and 2 of these are A/D in
Env. CRF35_A1D Env is A1, with a small region in the
C4/C5 region being subtype D, while CRF50_A1D has
breakpoints between C1 and C3 (http://www.hiv.lanl.-
gov). Again, when Env function is required, recombin-
ation events in env tend to cluster in the leader-C1
region of gp120 or in the transmembrane domain of
gp41 [30, 31]. In the absence of functional selection,
intersubtype recombination is quite prevalent in the
other conserved regions C2, C3, and C4 and still evi-
dent in the hypervariable sequences. Previous studies
indicate that cross-overs/breakpoints can occur any-
where on the template during reverse transcription but
are more frequent at regions of higher sequence con-
servation [30, 31].
The absence of functional intersubtype recombinants
with breakpoints between the C1 and C5 domains of
HIV-1 gp120 may be associated with co-evolving inter-
actions between the linear ends of the gp120 and withthe ecto domain of gp41. Galli A, et al. studied the recom-
bination in pol region between two subtype B sequences
(B/B) and between one subtype B and one subtype F se-
quence (B/F), and found the evidence for the evolved co-
adapted sites in variants from different subtypes [39]. Nu-
merous studies have mapped possible interaction between
the gp120 C1 and C5 domains with the ecto domain of
gp41, which is now supported by a recent 4.7 Å crystal
structure of a soluble, cleaved BG505 SOSIP.664 gp140
trimer in complex with a potent broadly neutralizing anti-
body (bnAb), PGT122, and recent 5.8 Å cryo-electron mi-
croscopy re-construction of the Env trimer in complex
with a CD4 binding site bnAb, PGV04 [36–38, 40–44]. In
Fig. 7, we have utilized the crystal structure coordinates of
the Env trimer (PDB - 4NCO) to highlight the interaction
between the gp120 C1, C5, and ecto-gp41 domains (resi-
dues 1–126). For this model, the bnAb PGT122 is hidden,
viral membrane would be on top, and CD4/CCR5 would
engage at the bottom of each view (Fig. 7a). The Env tri-
mer “core” containing the close association between C1,
C5, and ecto-gp41 domains of each gp120 subunit is
shown by turning the structure 90° clockwise (Fig. 7b) and
by being stripped of all other gp120 residues (Fig. 7c).
These trimer domains are less exposed and more encased
by the remaining gp120 regions (Fig. 7d).
Fig. 4 Influence of discordance in tat/rev exon 1 and 2 on HIV-1 intersubtype envA/D recombinant envelopes. The tat exon 1 sequence from
isolate D109 was cloned into the non-functional plasmids containing entire envs from HIV-1 A91, A115 and D109 parental virus (a and d), env
recombinants from A91/D109 pair (b and e) and from A115/D109 set (c and f) which were subjected to Veritrop assay and virus replication
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between C1, C5, and ecto-gp41 domains despite the
~340 amino acids separating this N and C terminus in
the linear sequence. Thus, lack of “functional” intersub-
type recombinations with breakpoints between the C1
and C5 domains may be related to the inability of the
subtype A C1 domain to interact with the subtype D C5
and ecto-gp41 domains. If this is the case, we should ob-
serve co-evolution between the C1 and C5/ecto-gp41
domains within a subtype. As described in the Methods
and Fig. 8, we constructed separate maximum likelihood
trees on the coding regions of C1, C2, C3, C4, C5/ecto-
gp41 domains using 144 and 97 unique subtype A1 and
D Env sequences (100 bootstrap replicates for each), and
using the rtREV [45] model for phylogenetic inference of
amino acid substitutions. We then compared the tree
topology of each matched terminal taxa in the tree for
all pairs of conserved Env regions (e.g. C1 + C2, C1 + C3,
C1 + C4, C1 + C5/ecto-gp41, etc.) using Mirrortree web
server [46] which was developed to predict functional
relationships between protein families. In other words,
relative genetic distances between all 144 branches of
the subtype A1 tree of C1 domain are compared to that
of the subtype A1 tree of C2 domain. Heatmaps demon-
strating the correlation between each paired domain in
Env were produced with Plot (https://plot.ly). Tosimplify, the strongest co-evolution between two con-
served Env domains would have the best overlay be-
tween tree topology of those conserved regions and
show the strongest correlation. With both subtype A1
and D, the C1 domain shows the strongest co-evolution
with the C5/ecto-gp41 domain (r = 0.44 and 0.47, re-
spectively) (Fig. 9a and c) comparing with other regions,
e.g. C3 domain (Fig. 9b, and d). Interestingly, linear
order of the conserved regions does not exhibit consist-
ent evidence of co-evolution along the length of the
gene, indicating that the proximity of the regions to each
other was not the driving factor of covariance (i.e. co-
evolution). For example, C1 is separated from C2 by ~66
amino acids (V1/V2) and shows a moderate pattern of
covariance (r = 0.26–0.39), while C3 and C4, who are
separated by a much shorter distance of ~11 amino
acids, show a weak pattern of covariance (r = 0.07–0.22).
To further predict protein co-evolution, we used the
methods developed in Pazos and Valencia [47], which
are similar to the methods implemented in mirrortree
with the exception that phylogeny of the viruses is not
taken into consideration since correlation is based solely
on the underlying distance matrices. The Jones-Taylor-
Thornton (JTT) matrix-based model [48] uses a uniform
substitution rate among sites to calculate the number of
amino acid substitutions per site between each sequence
Fig. 5 Cloning of only gp120 sequences of intersubtype envA/D recombinants into NL4-3 backbone and the resultant envelope function assay.
Intersubtype A/D recombinant gp120 genes were cloned, leaving gp41 of NL4-3 intact. (a) The plasmids containing recombinant gp120 sequences
were tested by Veritrop assay for functionality and (b) for replication-competent virus production. Pseudoviruses produced from the plasmids were
tested by ELISA (c) and Western blot (d) for the production of envelope expression
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for paired conserved region (C1, C2, C3, C4, and C5-
gp41) of every virus in the multiple sequences, generat-
ing 10,296 and 4656 data points for subtype A1 and D
viruses. Pearson’s product-moment correlation coeffi-
cient was calculated to measure the relationship between
the distances paired conserved regions for these viruses.
As in the analysis of the maximum likelihood treeFig. 6 Cloning of only V1-V5 domains of envA/D recombinants into NL4-3 ba
9 envA/D recombinants were cloned into NL4-3 backbone, and were tested fo
replication-competent viruses (b)topology described above, the strongest correlations
existed between C1 and C5-gp41 (Fig. 9e and f).
Discussion
We and others have mapped intersubtype recombination
in the env gene using various HIV-based systems. The
frequency and site of intersubtype recombinations is
governed by sequence conservation, RNA secondaryckbone and the resultant envelope function assay. The V1-V5 domains of
r their functionality by Veritrop assay (a) and for their ability to produce
Fig. 7 Model of the C1/C5/ecto-gp41 core in the crystal structure of the HIV-1 gp140 trimer. This figure is derived from the recent 4.7 Å crystal
structure of a soluble, cleaved BG505 SOSIP.664 gp140 trimer in complex with a potent bnAb, PGT122 [37] (PDB - 4NCO). The interaction between the
gp120 C1, C5, and ecto-gp41 domains is highlighted. For this model, the bnAb PGT122 is hidden, viral membrane would be on top, and CD4/CCR5
would engage at the bottom of each view. The Env trimer “core” of the C1, C5, and ecto-gp41 of each gp140 subunit is shown in panel (a), turned
90O in (b), and stripped of all other gp120 residues in panel (c). Finally, each gp140 subunit of the trimer is shown in panel (d)
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replication [1, 30, 33, 49, 50]. However, few studies [1,
33, 51] have characterized the function of these intersub-
type recombinant genomes generated in vitro. Our la-
boratory has developed several systems to understand
the mechanisms involved in HIV-1 recombination. Early
studies explored the generation of intersubtype HIV-1
recombinants in the env gene by dually infected suscep-
tible cell cultures with HIV-1 subtypes that co-circulated
in regional epidemics [31, 32]. Dual infection generally
produces intersubtype recombinant viruses at low fre-
quency that are defective or that cannot compete with
the parental viruses. To enrich for “functional” recombi-
nants, we utilized HIV isolate-specific siRNAs that pre-
vented outgrowth of parental viruses while permitting
replication of intersubtype recombinants with break-
points that “recombined out” the siRNA target se-
quences [2]. With both studies, the preliminary evidence
still suggested that intersubtype breakpoints in gp120
led to non-functional envelopes and defective viruses.However, we did not employ a systematic approach to
investigate the impact of intersubtype recombination in
the env gene on function and support of HIV-1 replica-
tion. The mechanism of HIV-1 intersubtype recombin-
ation during reverse transcription does not, of course,
account for the functionality of the resulting genomes,
which is largely controlled by the minus strand DNA in-
vasion onto another HIV-1 RNA genome during pausing
of reverse transcriptase at homopolymeric tracts or RNA
secondary structures. Again, these strand transfer events
occur at increased frequency in regions of high sequence
conservation [1, 30], which could lead to selection of
more functional intersubtype. Based on this process,
intersubtype recombination can often result in split co-
dons (i.e. non-synonymous amino acid substitutions), in-
sertions, deletions, and substitutions that can change the
open reading frames and/or introduce premature stop
codons.
In this study, we have screened out all of the intersub-
type recombination events in env that obviously impact
Fig. 8 Schematics of Phylogenetic/coevolution analyses. (a) Full length subtype A1 and subtype D envelope amino acid sequences downloaded
from the Los Alamos National Laboratory HIV sequence database were filtered and resulted in data sets containing 144 and 97 unique sequences
of subtype A1 and subtype D, respectively. Subtype specific alignments were performed using MUSCLE and then trimmed to the positions
containing the C1–C5 regions and the ecto-gp41 domain. (b) Maximum likelihood trees were generated for each region using the algorithms
implemented in PHYML with 100 bootstrap replicates, and the tree topology search was performed using Nearest Neighbor Interchanges (NNIs).
The phylogeny of the regions was estimated using the rtREV model of amino acid substitution. The resulting maximum likelihood trees were used
as input to the Mirrortree web server. (c) Pairwise distance matrices of each region were built with MEGA, which used a JTT matrix-based model
and a uniform substitution rate among sites, to calculate the number of amino acid substitutions per site/residue from between each sequence
in the alignment. Correlation between each conserved region in gp120 or the gp41 domain were then measured by Pearson’s product-moment
correlation coefficient, and significance estimated with Fisher’s exact test
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Fig. 9 (See legend on next page.)
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Fig. 9 Co-evolution of the C1/C5/ecto-gp41 domains in HIV-1 subtype A and D isolates. Scatter plots demonstrating the correlation between the
pairwise distance matrices of viral isolates were built from multiple sequence alignments of unique subtype A1 and subtype D env sequences
(n = 10,296, (a) and (b); n = 4657 (c) and (d), respectively). Pairwise comparisons were performed with all pairs of conserved C1, C2, C3, C4, and
C5-gp41 regions but only the comparison of C1 + C5/gp41 (a and c) and of C1 + C3 (b and d) are presented in this figure. Pearson product
moment correlations are shown for each panel but due to high number of sample sequences, p values were highly significant (<0.0001) for all
paired analyses suggesting some level of co-evolution throughout the protein as expected. The heatmaps in (e) and (f) reflect the tree correlation
coefficients derived from a similarity comparison of the maximum likelihood derived trees of the multiple sequence alignments of the subtype
specific conserved regions. The correlation coefficients between C1 and C5-gp41 demonstrate the strongest similarity of tree topology among the
regions compared
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type recombination events with intact open reading
frames that Env expression may or may not generate a
functional chimeric protein. The HIV-1 env gene con-
tains tat2 and rev2 exons that must be precisely spliced
and joined to tat1 and rev1 exons to produce functional
Tat and Rev proteins [26, 27]. There is a significant
intersubtype sequence variability in both tat and rev se-
quences and there is evidence of co-evolution within the
first and second exons of these accessory genes as well
as within the TAR and RRE RNA target sequences [28,
29]. A recombination breakpoint in the gp120 coding se-
quence would result in an intersubtype discordance in
tat1 and tat2 or rev1 and rev2, which impact Tat and
Rev expression as well as their function. Intersubtype A/
D recombination in gp120 did not result in a frameshift
or premature stop codon due to combination of discord-
ant subtypes in the first and second exons. However,
there was the possibility that discordant subtype se-
quences for the first and second exons of tat/rev im-
paired their function. In the present study, we found
that two non-functional A/D env recombinants clones
(out of 21) in an NL4-3 backbone were “rescued” for
host cell entry and virus replication when “matching”
tat/rev exons 1 and 2 were introduced. Interestingly, the
other 19 A/D env recombinants clones in an NL4-3
backbone with the same functional Tat/Rev proteins re-
main non-functional, even though the Env glycopro-
teins were observed in all of these A/D recombinant
viruses, suggesting that the discordance of tat1/rev1
and tat2/rev2 might not play the main role in restrict-
ing the function of resultant HIV-1 A/D intersubtype
Env recombinants.
In the recombinant virus with surface expression of
the A/D envelope glycoprotein, the lack of replication
and host cell entry was most likely attributable to im-
paired function of this chimeric protein. Previous studies
have described the possible non-covalent interactions
between gp120 and gp41. The topology of the gp120
core structures implies that gp120 C1 and C5 are in
close proximity [52–54], and immunological studies have
also suggested interactions between the C1, C5, and thegp41 disulfide loop [23, 55]. The gp41 components are
membrane-proximal and interspersed with the gp120 C1
and C5 elements. These two HR1 helices pack against
hydrophobic gp120 residues in C1 and C5. The close
proximity of C1 and C5 elements most likely participates
in tertiary structure interactions with residues connect-
ing HR1 to HR2 [40, 56]. The thermodynamic stability
of this gp120–g41 interface is essential for the integrity
of HIV-1 envelope trimer structure and function [40,
57]. The non-covalent nature of gp120-gp41 interaction
presents significant challenges, for this contact must be
of sufficient flexibility to maintain subunit interactions
following gp120 binding to CD4 and subsequent gp120
conformational changes that promote its interaction
with the CCR5 or CXCR4 co-receptor. The authenticity
of this gp120–gp41 interaction for function is docu-
mented in experiments describing disruption due to
minor temperature change, antibody or soluble CD4
binding, and inhibitor binding [57–59]. Based on these
findings, we investigated if the expressed but non-
functional Env was due to subtype discordance between
the C1 and C5/ecto-gp41 domains introduced by inter-
subtype recombination in the gp120 coding region. First,
cloning of the A/D gp120 coding region did not restore
Env function or virus replication for any of the 9 se-
lected clones in the NL4-3 backbone. However, the clon-
ing of just V1-V5 regions resulted in a gain of function/
replication for 4 of these 9 envA/D recombinant viruses.
In this situation, the C1, C5/gp41 regions were retained
from NL4-3 but V1-V5 gp120 sequences contained an
upstream subtype A coding region fused to a subtype D
coding region. Despite the extreme chimeric nature of
the Env glycoprotein (e.g. subtype B-C1, A-V1 to V3, D-
C4 to V5, B-C5 and B-gp41 for clone bk7169), many of
these viruses with the A/D gp120 V1-V5 regions were
functional. In contrast, a virus encoding the recombinant
breakpoint as an Env cassette (e.g. subtype A–C1 to V3
and subtype D-C4 to gp41 for clone bk7169) could not
mediate host cell entry and could not replicate despite
having Env expression on the viral particle surface. Inter-
estingly, Simon-Loriere et al found that defective intersub-
type recombinants were most frequently observed in the
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nants and less so in A/G and A/B env recombinants.
Those nonfunctional intersubtype recombinants with
C2 and C3 breakpoints may also be related to the co-
evolution and interaction of the C1, C5 and gp41 do-
mains [60].
The importance of this C1/C5/ecto-gp41 interaction
for Env function is best supported by the recent 3 Å X-
ray crystal structure of gp140 trimer in complex with a
potent bnAb, PGT122 and the 5.8 Å cryo-electron mi-
croscopy re-construction of the Env trimer in complex
with a CD4 binding site bnAb, PGV04 [36–38, 40–44].
In this study, we have utilized the available crystal struc-
ture coordinates to visualize this C1/C5/ecto-gp41 inter-
action within the gp140 trimer. As described in Fig. 7,
the C1/C5/ecto-gp41 domains wrap together to form an
inner core within the gp140 trimer. Thus, it is not sur-
prising that major genetic shifts within this structure
(e.g. intersubtype recombination events) may prevent
proper Env function. This highly conserved structural
motif may also be one of the reasons for the paucity of
intersubtype recombination breakpoints in the gp120
coding region within the HIV-1 population but signifi-
cant hot spots for recombination prior to the C1 region
and following the ecto-gp41 domain of Env (http://
www.hiv.lanl.gov/).
The close interaction between the C1/C5/ecto-gp41
domains within Env glycoprotein trimers suggests a pos-
sible co-evolution (co-variance) within these domains
during HIV-1 divergence in the human epidemic. We
specifically analyzed env sequences from a representative
set of 144 and 97 unique HIV-1 subtype A1 and D iso-
lates (http://www.hiv.lanl.gov) using two maximum like-
lihood/matrix models to test for co-evolution among
gp120-C1,—C5, and ecto-gp41 domains. Based on these
models, C1 and C5/ecto-gp41 domains had higher co-
variance/co-evolution than any other paired gp120/gp41
regions (e.g. C1 + C2, C1 + C3, C1 + C4, etc.). Previous
mutational analyses revealed evidences for C1, C5 and
ecto-gp41 interactions. For example, V44A and F53A
mutants can disrupt gp120/gp41 interactions [44]
whereas gp120 mutations V36L and Y40D resulted in
dissociation of gp120 from gp41 [61] despite interactions
with cellular CD4 receptor [61]. C1 and C5 domains of
gp120 form the two alpha helices that constitute the
hydrophobic inner core that directly interacts with the
immunodominant loop in the gp41 ectodomain [40, 42,
44]. Mutational studies revealed interactions between
I491 of C5 and W596/S618 of the gp41 immunodomi-
nant loop [42, 62] and an additional A501 of C5 inter-
acting with T605 of this gp41 loop [40]. Biochemical
mapping of these C1/C5/ecto-gp41 interactions have
now been confirmed with the recent gp140 trimer struc-
ture, which now suggests that many of these interactionsare inter- as opposed to intramolecular interactions
within the trimer C1/C5/ecto-gp41 core. Based on the
present study, we cannot assume that breakpoints within
the gp120 region would result in non-functional gp120
recombinants between other subtypes. However, with se-
lection pressure for replication competency, we have
rarely observed breakpoints within the gp120 of other
intersubtype recombinants (http://www.hiv.lanl.gov/).
Through analyzing 77 functional various intersubtype
recombinants with single breakpoints in the env coding
region, we have found that only 5 % have recombin-
ation sites in gp120. We are currently exploring the
possible linked amino acids in the C1, C5 and ecto-
gp41 domains that may interact in the gp140 trimer. As
opposed to just structure-based mutagenesis studies,
we can also identify key amino acid residues and struc-
tures in the trimer C1, C5 and ecto-gp41 core using a
combination of co-evolution studies along with analyses
of functional intersubtype recombinants in env.
Conclusions
Studies on the gp120/gp41 structure of HIV-1 intersub-
type Env recombinants could be the key to understand-
ing the labile C1/C5/ecto-gp41 interface and could help
in design of drugs to disrupt this interaction. Our study
on HIV-1 env gene evolution in the epidemic reveals a
strong link and co-evolution between the C1, C5 and
ecto-gp41 domains which is less apparent between other
subdomains of gp120 and gp41. These findings suggest a
strong selective pressure for co-evolution in the C1, C5
and ecto-gp41 domains to maintain Env function and
virus replication. In this study we have identified two
mechanisms responsible for the genetic bottlenecks that
select for specific replication-competent intersubtype
Env recombinants. Of course, this was following the ex-
clusion of the obvious that prevented Env expression, i.e.
premature stop codons, insertions/deletions, and frame-
shifts. First, recombination within the gp120 coding re-
gion can generate non-functional or defective Rev and
Tat proteins due to subtype/isolate discordance between
the first and second exons of these accessory genes. Sec-
ond, recombination within the gp120 coding region can
introduce subtype/isolate discordance that disrupts the
highly conserved C1/C5/ecto-gp41 interactions involved




A91 and A115 are HIV-1 subtype A strains, and D109 is
HIV-1 subtype D strain, and they were all CCR5-tropic vi-
ruses. These viruses were collected from treatment-naive
HIV-1-infected pediatric patients under IRB approval and
patients consent through Joint Clinical Research Center
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their mothers had received any ARV treatment. The vi-
ruses were isolated and propagated by co-culturing Per-
ipheral blood mononuclear cells (PBMCs) from the
patients and from HIV seronegative blood donors as pre-
viously described [63]. PBMCs were obtained by Ficoll-
Hypaque density gradient centrifugation of heparin-
treated venous blood. Prior to HIV-1 infection, cells
were stimulated with 2 μg of phytohemagglutinin
(PHA) (Gibco BRL) per ml for 3 to 4 days and main-
tained in RPMI 1640– 2 mM L-glutamine medium
(Cellgro) supplemented with 10 % fetal bovine serum
(FBS, Cellgro), 1 ng of interleukin-2 (IL-2) (Gibco BRL)
per ml, 100 U of penicillin (Cellgro) per ml, and 100 μg
of streptomycin (Cellgro) per ml. TCID50 assays (tissue
culture dose for 50 % infectivity) were performed to de-
termine virus titer. Titers were expressed as infectious
units per milliliter [64]. The sequence analysis of env
genes of these three HIV-1 isolates were typical subtype
A or D viruses.
Cell lines
U87.CD4.CCR5 cell line was obtained from the AIDS Re-
search and Reference Reagent Program and grown in Dul-
becco’s modified Eagle’s medium (DMEM, Invitrogen)
supplemented with 15 % FBS, penicillin and streptomycin,
puromycin (1 μg/ml) and G418 sulfate (1 mg/ml). HEK-
293 T cells were obtained from the American Type Cul-
ture Collection and grown in DMEM supplemented with
10 % FBS and penicillin and streptomycin. All cells were
grown at 37 °C in 5 % CO2.
Intersubtype recombination by dual infection
Production of intersubtype recombinant HIV-1 through
in-vitro dual infection has previously been described
[32]. One hundred and twenty thousand U87.CD4.CCR5
cells in a 12 well plate were inoculated with 0.1 multipli-
city of infection (MOI) of each of primary HIV-1 isolate
pair A91 and D109, or A115 and D109. Monoinfections
were also set up as controls alongside the dual infections.
The viruses were grown for 7 days before culture super-
natant was harvested. HIV-1 viral RNA was extracted
from the collected supernatant using the QIAamp Viral
RNA mini kit (Qiagen), and was immediately used for Re-
verse transcription PCR (RT-PCR, see below).
Reverse transcription PCR, PCR, and TOPO cloning
Viral RNA was extracted from 140 μL of culture super-
natant using the QIAmpViral RNA mini kit (Qiagen),
and was converted into cDNA by using Moloney murine
leukemia virus RT (M-MLV, Invitrogen) and primer
ENV-N (antisense, HXB2 numbering nt9146 to nt9172,
5′-CTGCCAATCAGGGAAGTAGCCTTGTGT-3′).
Briefly, 5 μl of extracted viral RNA was mixed with 40pmol of primer ENV-N, and cycled for 88 °C for 2 min,
70 °C for 10 min, 55 °C for 10 min, 37 °C for 10 min,
and 4 °C hold. Next, 4 μl 5× first strand buffer (Invitro-
gen), 2 μl 0.1 M dTT (Invitrogen), and 1 μl 10 mM
dNTPs were added to each reaction and cycled at 25 °C
for 10 min, 42 °C for 2 min, and a 4 °C hold. Finally, M-
MLV RT was added to the reaction and cycled at 42 °C
for 1 h, 70 °C for 15 min, and a 4 °C hold.
To retrieve full length recombinant envs from the cul-
ture, nested PCR was performed with external primers
ENV A (sense, nt5954 to nt5982, 5′-GGCTTAGGCATC
TCCTATGGCAGGAAGAA-3′) and ENV M (antisense,
nt9068 to nt9098, 5′- TAGCCCTTCCAGTCCCCCCTT
TTCTTTTA-3′) followed by internal primers Vpu-A-1
(sense, nt6135 to nt6155, 5′-TAGTAGGTATAGAATA
TAAGA-3′) and gp41-D-2 (antisense, nt8747 to nt8769,
5′-GCCTAATTCTTCTAGGTATGTTG-3′). PCR ampli-
fications were performed with the following conditions:
94 °C 4 min, [94 °C 30 s, 55 °C 30 s, 72 °C 3 min] × 35 cy-
cles, and 4 °C hold. Please note, in order to eliminate the
possible PCR-induced env recombinants, we used Phusion
High-Fidelity DNA Polymerase (NEB) which can rapidly
complete the DNA extension (15–30 s per Kb) and longer
extension time (3 min) than the requested 1.3 min. PCR
products (~2.6 kb) of HIV-1 recombinant envs were gel
purified with a QIAquick gel extraction kit (Qiagen), and
were cloned into TOPO-TA PCR cloning vector (Invitro-
gen) which was then transformed into OneShot Top10 E.
coli cells (Invitrogen) according to manufacturer’s instruc-
tions. The transformed cells were plated onto LB (Luria-
Bertani) plates containing 100 μg/ml ampicillin, X-gal and
Isopropyl β-D-1-thiogalactopyranoside (IPTG). The
yielded clones were grown for plasmid extraction using a
QIAamp plasmid miniprep kit (Qiagen) and the resultant
DNA was sent for clonal sequencing. Full-length and V1-
V5 domains of recombinant gp120 were amplified from
TOPO vectors using sense primer VPU-A-1, and different
antisense primers gp120-D-2 (nt7617 to nt7642, 5′-
CCTCCTCCAGGTCTGAAGGTTTCATT-3′) and V5-
D-2 (nt7373 to nt7399, 5′-TTAAACATATGTGTTG
TAATCTCTAA-3′) respectively. To further exclude the
possible recombinants generated by the Taq polymerase
jumping between the templates, we set up a control PCR
by using the mixed proviral DNAs from the monoinfec-
tions with subtype A or D isolates. The results showed
that the frequency of these background recombinants was
always lower than 0.5 %, or at least 20- fold less than the
HIV-1 recombination frequency obtained with heterozy-
gous virions.
Cloning of full length recombinant envs and gp120s into
NL4-3 backbone
The pREC_nfl_HIVNL4-3 vector containing a near full
length (nfl) HIV-1 isolate NL4-3 backbone has previously
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ent HIV genes to create various chimeric HIV-1 viruses
through yeast gap repair homologous recombination [2,
65, 66]. To clone an HIV-1 sequence into pRE-
C_nfl_HIVNL4-3 vector, the corresponding region in the
NL4-3 backbone is first replaced with the yeast oroti-
dine 5-phosphate decarboxylase (URA3) gene using
specific primers tagged with 40–60 nucleotides to allow for
homologous recombination at either side of the target se-
quence. We created cloning shuttle plasmids pREC_nfl_HI-
VΔenv/URA3, pREC_nfl_HIVΔgp120/URA3, pREC_nfl_
HIVΔV1-V5/URA3 and pREC_nfl_HIVenvA/DΔtat1/URA3
for cloning full length recombinant HIV-1 env, gp120,
gp120 V1-V5 domains and D109 tat1 respectively. To clone
the URA3 products into the NL4-3 backbone to create the
corresponding shuttle plasmids, The Saccharomyces Cere-
visiae yeast MYA-906 (genotype MATα-ade6-can1-his3-
leu2-trp1-URA3) was grown in 5 ml YEPD media at 30 °C
on a shaking platform overnight. After 12–16 h, 0.5 ml of
the yeast culture was inoculated in 50 ml YEPD media
and grown for 4–6 h to attain an OD600 of 1.0. The yeast
was washed in 1 ml of sterile water and resuspended in
1 ml of fresh 1× LiAc/TE solution in water [LiAc
(100 mM pH 7.5) and TE (10 mM Tris-Cl pH 7.5 and
1 mM EDTA pH 8.0)] to induce competence and then
chilled on ice. The PCR inserts (3 μg) and the linearized
pREC_nfl_HIVNL4-3 plasmid (1 μg) were then co-
transformed along with 50 μg of denatured salmon sperm
carrier DNA (BD Biosciences/Clontech, Palo Alto, CA)
into yeast using the lithium acetate-PEG. The mixture
was incubated on a shaking platform at 30 °C for
30 min followed by a 15 min heat shock at 42 °C and
then plated on complete supplement media (CSM)-
LEU-URA agar plates in which only the yeast contain-
ing successful replacement of certain HIV sequences
(i.e. env, gp120, V1-V5, or tat1/env) by URA3 gene can
grow. Plasmids were retrieved from yeast clones using a
mixture of mechanical glass bead disruption and
phenol-chloroform-IAA extraction, and 4 μL of the
crude yeast preparation was transformed into STBL4
E.coli (Invitrogen). The shuttle plasmids pREC_nfl_HI-
VΔenv/URA3, pREC_nfl_HIVΔgp120/URA3, pREC_
nfl_HIVΔV1-V5/URA3 and pREC_nfl_HIVenvA/DΔtat1/
URA3 were finally extracted from STBl4 E. coli and
were used for the subsequent experimentation.
To clone the different PCR products into their corre-
sponding shuttle plasmids, the same yeast transformation
procedure was performed, but with different shuttle vectors
and selected on CMM-Leu + 5-fluoro-1,2,3,6-tetrahydro-
2,6-dioxo-4-pyrimidine carboxylic acid (5-FOA) plates in
which only the yeast containing the shuttle vector with
successful replacement of URA3 by the corresponding
HIV-1 env (or gp120, V1-V5, and tat1/env) recombi-
nants can survive and generate pREC_nfl_HIVenvA/D,pREC_nfl_HIVgp120A/D, pREC_nfl_HIV_V1-V5A/D and
pREC_nfl_HIVtat1/envA/D.
Veritrop assay
One million U87.CD4.CCR5 cells were plated in 100 mm
petri dishes (Day 1), and 24 h later (Day 2), were trans-
fected with pDM.128-fLuc plasmid using FuGENE 6
transfection reagent (Roche). On day 1 also, 6.5 × 104
HEK-293 T cells (per well) were plated in 24-well plate,
and 24 h later (Day 2), were transfected with pRE-
C_nfl_HIV plasmid containing the respective env
recombinant inserts. Six hours post-transfection,
U87.CD4.CCR5 cells were plated into a 24-well plate
at 6.5 × 104 cells per well. On day 3, transfected HEK-
293 T cells from each well were collected and 6.5 × 104
cells were layered over the seated 87.CD4.CCR5 cells
and co-cultured for an additional 15 h. Lastly, the cells
were lysed with 100 μl of Glo Lysis Buffer for 15 min
at room temperature, and then 50 μl of lysate was
mixed with 50 μl of Bright Glo (Promega Biotech) and
luminescence was read on Victor3 V (Perkin Elmer)
luminometer for luciferase activity.
Virus production
Production of infectious HIV-1 from pREC_nfl_HI-
VenvA/D (or pREC_nfl_HIVgp120A/D, pREC_nfl_
HIV_V1-V5A/D, and pREC_nfl_HIVtat1/envA/D) vec-
tors containing various A/D env recombinants were
done according to Dudley et al. [34]. Briefly, on day 1,
7 × 104 HEK-293 T cells/well were plated, and 24 h
later (Day 2), 0.3 μg of each of the pREC_nfl_HI-
VenvA/D plasmids containing various HIV-1 A/D env
recombinant sequences were co-transfected with an
equal amount of a complementing plasmid pREC_5′
LTR_gag/pol (containing only the R, U5, PBS, uncod-
ing regions, gag, and partial pol sequences) [67]. The
next day (day 3) 7 × 104 U87.CD4.CCR5 cells were
plated in a 24 well plate, and infected 24 h later (Day
4) by transfer of the supernatant from the transfected
HEK-293 T cells. After 24 h, infection supernatant was
washed off and the U87.CD4.CCR5 cell cultures main-
tained for up to 2 weeks following infection. Virus
replications in U87.CD4.CCR5 cell culture were moni-
tored by visually monitoring syncytia appearance and
measuring reverse transcriptase activity every 2–3
days. Supernatant from infected wells was harvested
and frozen at—80 °C for future use.
Reverse transcriptase-activity assay (RT Assay)
Ten microliter of cell culture supernatant was collected
into a 96-well plate every other day and subjected to RT
activity assay as previously described [68]. Briefly, 10 μl
of transfected and/or infected supernatant was incubated
at 37 °C overnight in the presence of 25 μl RT mixture
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master mix: 50 mM Tris-HCl (pH 7.8), 75 mM KCl,
2 mM DTT, 5 mM MgCl2, 5 μg/ml of poly(rA), 6.25 μg/
ml oligo(dT), and 0.5 % (v/v) NP40). After incubation,
10 μl of the reaction mixture was blotted from each well
onto the 96-well format DEAE filtermat. After 10 min of
drying, the filtermat was washed five times with 1 × SSC
solution and twice with 85 % ethanol (5 min for each
time) in a shaking platform. The filters were then wrapped
with Saran wrap and either exposed overnight onto auto-
radiography film (Kodak BioMax MR) or counted with a
Matrix 96 β-counter (Packard, Meriden, CT) to acquire
the quantitative RT activity.
Clonal sequencing
We procured commercial sequencing services of ACGT,
Inc (Wheeling, Illinois). Full length envs were sequenced
using five universal primers Vpu-1 (nt6108–6130; sense, 5′-
TAATAATAGCAATAGTTGTGTGG-3′), E80 (nt6862-
6883; sense, 5′-TTCCAATACACTATTGTGCTCC-3′),
EAD2 (nt8064–8084; antisense, 5′-CCAGAGATTTAT
TACTCCA-3′), E15 (nt8424–8425; antisense, 5′-CTTG
CTCTCCACCTTCTTCTTC-3′) and ENVM (nt9068–
9096; antisense, 5′-TAGCCCTTCCAGTCCCCCCTTTTC
TTTTA-3′). Sequencing chromatographs were physically
inspected to ensure accuracy of sequencing data, and frag-
ments were joined to form full length envs and aligned
along with primary envs of isolates A91, A115, and D109
with BioEdit Sequence analysis software. Aligned sequences
were imported into SimPlot sequence similarity plotting
software and bootstrap plots were constructed with the re-
combinant sequences as the query and the two recombin-
ing primary envs as the references. The Kimura-2
parameter model was used for analysis with a 200 and 20
base pair window and step respectively.
In-house ELISA
Costar 96-well EIA/RIA plates (Immunochemistry tech-
nologies) were coated with 100 ng/well of concentrated
pseudoviruses or with commercially obtained recombin-
ant HIV-1 gp140 (UG37) (as a positive control). Detec-
tion of envelope expression on pseudoviruses was done
using of b13 monoclonal antibody (provided by George
Lewis, Institute of Human Virology, Baltimore, MD, and
Bruce Chesebro, NIAID, Hamilton, MT), followed by
addition of rabbit anti-mouse IgG-HRP conjugate anti-
body (Promega Cat#W4021) at a dilution of 1:2500, and
TMB substrate. The reaction was stopped with 1 N sul-
furic acid, the developed chromogen was read at λ =
450 nm, and the optical density (OD) was plotted.
Western blot
HIV-1 viral Env proteins were detected by Western blot.
Blots were performed on virus pelleted from the culturesupernatants. Virus-containing supernatants were clari-
fied of cellular debris by centrifugation (2500 rpm,
15 min) and virions were pelleted by centrifugation at
32,000 rpm for 1 h. Samples were resuspended in so-
dium dodecyl sulfate (SDS) lysis buffer (40 mM Tris-
HCl [pH 6.8], 10 % glycerol, 10 % β-mercaptoethanol,
1 % SDS) and heated to 95 °C for 5 min, separated by
SDS-10 % polyacrylamide gel electrophoresis, and
transferred to nitrocellulose. Membranes were blocked
with 5 % milk, incubated with the B13 antibody and
then with horseradish peroxidase-conjugated secondary
antibodies, detected with the ECL Plus kit (Amersham
Biosciences, Piscataway, NJ), and finally exposed to x-
ray film.Phylogenetic/coevolution analyses
Intra-protein coevolution may be inferred by quantifying
the degree of similarity of phylogenetic tree structure of
two protein domains based on the correlation of the dis-
tance matrices used to build the trees [47]. To measure
the covariance between the conserved regions of gp120
and the gp41 extracellular domain, full length subtype
A1 and subtype D envelope amino acid sequences were
downloaded from the Los Alamos National Laboratory
HIV sequence database (http://www.hiv.lanl.gov/). The
sequences were filtered to include one sequence per pa-
tient and sequences with more than one ambiguous
codon were removed, which resulted in data sets con-
taining 144 and 97 unique sequences, respectively. Sub-
type specific alignments were performed using MUSCLE
[69] then trimmed to the positions containing the C1–
C5 regions and the ecto-gp41 domain (Fig. 8a). Max-
imum likelihood trees were generated for each region
using the algorithms implemented in PHYML [70] with
100 bootstrap replicates, and the tree topology search
was performed using Nearest Neighbor Interchanges
(NNIs). The phylogeny of the regions was estimated
using the rtREV [45] model of amino acid substitution,
which was developed specifically for phylogenetic infer-
ence of retroviral sequence. The equilibrium frequencies
and the gamma distribution were both estimated by the
model, and the number of substitution rate categories
was set to 4. The resulting maximum likelihood trees
were used as input to the Mirrortree web server [46]
which was developed to predict functional relationships
between protein families based on the tree topology of
the proteins or domains being compared (Fig. 8b). This
algorithm implements the tree correlation method de-
veloped by Pazos and Valencia [47] that creates a dis-
tance matrix for each tree by summing the branch
lengths that separate the taxa in the tree, and then esti-
mating the linear correlation coefficient (r) between the
two matrices. Heatmaps demonstrating the correlation
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(https://plot.ly).
Additionally, pairwise distance matrices of each region
were built with MEGA [71], which used a Jones-Taylor-
Thornton (JTT) matrix-based model [48] and a uniform
substitution rate among sites, to calculate the number of
amino acid substitutions per site/residue from between
each sequence in the alignment. Correlation between
each conserved region in gp120 or the gp41 domain
were then measured by Pearson’s product-moment cor-
relation coefficient, and significance estimated with Fish-
er’s exact test (Fig. 8c).
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